4
Changes in Ownership
Jasper Therapeutics, Inc. Filed Acc 0001213900-23-007992
Options or other derivatives
- President, CEO & Director acquired 1,093,831 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
MARTELL RON · President, CEO & Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-02-02 | Grant or award : show line 1 in the form Stock Option (right to buy) | +1,093,831 | 1,093,831 | D |
Loading xslF345X03/ownership.xml…